author_facet Hassel, Jessica Cecile
Forschner, Andrea
Blum, Leonie
Heinzerling, Lucie
Zimmer, Lisa
Utikal, Jochen
Kähler, Katharina C.
Schlaak, Max
Loquai, Carmen
Gutzmer, Ralf
Kiecker, Felix
Berking, Carola
Bender, Armin
Schneider, Lars
Enk, Alexander
Garbe, Claus
Weichenthal, Michael
Schadendorf, Dirk
Hauschild, Axel
Mohr, Peter
Hassel, Jessica Cecile
Forschner, Andrea
Blum, Leonie
Heinzerling, Lucie
Zimmer, Lisa
Utikal, Jochen
Kähler, Katharina C.
Schlaak, Max
Loquai, Carmen
Gutzmer, Ralf
Kiecker, Felix
Berking, Carola
Bender, Armin
Schneider, Lars
Enk, Alexander
Garbe, Claus
Weichenthal, Michael
Schadendorf, Dirk
Hauschild, Axel
Mohr, Peter
author Hassel, Jessica Cecile
Forschner, Andrea
Blum, Leonie
Heinzerling, Lucie
Zimmer, Lisa
Utikal, Jochen
Kähler, Katharina C.
Schlaak, Max
Loquai, Carmen
Gutzmer, Ralf
Kiecker, Felix
Berking, Carola
Bender, Armin
Schneider, Lars
Enk, Alexander
Garbe, Claus
Weichenthal, Michael
Schadendorf, Dirk
Hauschild, Axel
Mohr, Peter
spellingShingle Hassel, Jessica Cecile
Forschner, Andrea
Blum, Leonie
Heinzerling, Lucie
Zimmer, Lisa
Utikal, Jochen
Kähler, Katharina C.
Schlaak, Max
Loquai, Carmen
Gutzmer, Ralf
Kiecker, Felix
Berking, Carola
Bender, Armin
Schneider, Lars
Enk, Alexander
Garbe, Claus
Weichenthal, Michael
Schadendorf, Dirk
Hauschild, Axel
Mohr, Peter
Journal of Clinical Oncology
Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
Cancer Research
Oncology
author_sort hassel, jessica cecile
spelling Hassel, Jessica Cecile Forschner, Andrea Blum, Leonie Heinzerling, Lucie Zimmer, Lisa Utikal, Jochen Kähler, Katharina C. Schlaak, Max Loquai, Carmen Gutzmer, Ralf Kiecker, Felix Berking, Carola Bender, Armin Schneider, Lars Enk, Alexander Garbe, Claus Weichenthal, Michael Schadendorf, Dirk Hauschild, Axel Mohr, Peter 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2016.34.15_suppl.9558 Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP). Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2016.34.15_suppl.9558
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC45NTU4
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC45NTU4
institution DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
imprint American Society of Clinical Oncology (ASCO), 2016
imprint_str_mv American Society of Clinical Oncology (ASCO), 2016
issn 1527-7755
0732-183X
issn_str_mv 1527-7755
0732-183X
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str hassel2016outcomeon560metastaticmelanomammpatientstreatedwithpembrolizumabduringthegermanexpandedaccessprogrameap
publishDateSort 2016
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_unstemmed Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_full Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_fullStr Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_full_unstemmed Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_short Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_sort outcome on 560 metastatic melanoma (mm) patients treated with pembrolizumab during the german expanded access program (eap).
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2016.34.15_suppl.9558
publishDate 2016
physical 9558-9558
description
container_issue 15_suppl
container_start_page 9558
container_title Journal of Clinical Oncology
container_volume 34
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792324788003274755
geogr_code not assigned
last_indexed 2024-03-01T11:54:56.135Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Outcome+on+560+metastatic+melanoma+%28MM%29+patients+treated+with+pembrolizumab+during+the+German+Expanded+Access+Program+%28EAP%29.&rft.date=2016-05-20&genre=article&issn=1527-7755&volume=34&issue=15_suppl&spage=9558&epage=9558&pages=9558-9558&jtitle=Journal+of+Clinical+Oncology&atitle=Outcome+on+560+metastatic+melanoma+%28MM%29+patients+treated+with+pembrolizumab+during+the+German+Expanded+Access+Program+%28EAP%29.&aulast=Mohr&aufirst=Peter&rft_id=info%3Adoi%2F10.1200%2Fjco.2016.34.15_suppl.9558&rft.language%5B0%5D=eng
SOLR
_version_ 1792324788003274755
author Hassel, Jessica Cecile, Forschner, Andrea, Blum, Leonie, Heinzerling, Lucie, Zimmer, Lisa, Utikal, Jochen, Kähler, Katharina C., Schlaak, Max, Loquai, Carmen, Gutzmer, Ralf, Kiecker, Felix, Berking, Carola, Bender, Armin, Schneider, Lars, Enk, Alexander, Garbe, Claus, Weichenthal, Michael, Schadendorf, Dirk, Hauschild, Axel, Mohr, Peter
author_facet Hassel, Jessica Cecile, Forschner, Andrea, Blum, Leonie, Heinzerling, Lucie, Zimmer, Lisa, Utikal, Jochen, Kähler, Katharina C., Schlaak, Max, Loquai, Carmen, Gutzmer, Ralf, Kiecker, Felix, Berking, Carola, Bender, Armin, Schneider, Lars, Enk, Alexander, Garbe, Claus, Weichenthal, Michael, Schadendorf, Dirk, Hauschild, Axel, Mohr, Peter, Hassel, Jessica Cecile, Forschner, Andrea, Blum, Leonie, Heinzerling, Lucie, Zimmer, Lisa, Utikal, Jochen, Kähler, Katharina C., Schlaak, Max, Loquai, Carmen, Gutzmer, Ralf, Kiecker, Felix, Berking, Carola, Bender, Armin, Schneider, Lars, Enk, Alexander, Garbe, Claus, Weichenthal, Michael, Schadendorf, Dirk, Hauschild, Axel, Mohr, Peter
author_sort hassel, jessica cecile
container_issue 15_suppl
container_start_page 9558
container_title Journal of Clinical Oncology
container_volume 34
description
doi_str_mv 10.1200/jco.2016.34.15_suppl.9558
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC45NTU4
imprint American Society of Clinical Oncology (ASCO), 2016
imprint_str_mv American Society of Clinical Oncology (ASCO), 2016
institution DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4
issn 1527-7755, 0732-183X
issn_str_mv 1527-7755, 0732-183X
language English
last_indexed 2024-03-01T11:54:56.135Z
match_str hassel2016outcomeon560metastaticmelanomammpatientstreatedwithpembrolizumabduringthegermanexpandedaccessprogrameap
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical 9558-9558
publishDate 2016
publishDateSort 2016
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Hassel, Jessica Cecile Forschner, Andrea Blum, Leonie Heinzerling, Lucie Zimmer, Lisa Utikal, Jochen Kähler, Katharina C. Schlaak, Max Loquai, Carmen Gutzmer, Ralf Kiecker, Felix Berking, Carola Bender, Armin Schneider, Lars Enk, Alexander Garbe, Claus Weichenthal, Michael Schadendorf, Dirk Hauschild, Axel Mohr, Peter 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2016.34.15_suppl.9558 Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP). Journal of Clinical Oncology
spellingShingle Hassel, Jessica Cecile, Forschner, Andrea, Blum, Leonie, Heinzerling, Lucie, Zimmer, Lisa, Utikal, Jochen, Kähler, Katharina C., Schlaak, Max, Loquai, Carmen, Gutzmer, Ralf, Kiecker, Felix, Berking, Carola, Bender, Armin, Schneider, Lars, Enk, Alexander, Garbe, Claus, Weichenthal, Michael, Schadendorf, Dirk, Hauschild, Axel, Mohr, Peter, Journal of Clinical Oncology, Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP)., Cancer Research, Oncology
title Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_full Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_fullStr Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_full_unstemmed Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_short Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
title_sort outcome on 560 metastatic melanoma (mm) patients treated with pembrolizumab during the german expanded access program (eap).
title_unstemmed Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2016.34.15_suppl.9558